1. Role: Director. Scope: Department. Date: 2019.
Grant H. Skrepnek, Ph.D., R.Ph.
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47105
Fax (4050 271-6430
Office CPB 214
Email grant-skrepnek@ouhsc.edu
Summary
I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Research
Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Publications & Presentations
- 101. Plaza C M, Draugalis J R, Slack M K, Skrepnek G H, Sauer K A. Use of reflective portfolios in health sciences education. American journal of pharmaceutical education. 2007; 71 : 34
102. Armstrong E P, Skrepnek G H, Haim Erder M. Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. Current medical research and opinion. 2007; 23 : 251-8
103. Ventura D, Armstrong E P, Skrepnek G H, Haim Erder M. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Current medical research and opinion. 2007; 23 : 245-50
104. Elliott W J, Plauschinat C A, Skrepnek G H, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. Journal of the American Board of Family Medicine : JABFM. 2007; 20 : 72-80
105. Skrepnek G H. The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis. PharmacoEconomics. 2007; 25 : 649-64
Grants
- 6. C1097002 - Improving evidence-based antibiotic use for treatment of infections commonly seen in long term . Federal Non-NIH. Start Date: 2019. End Date: 2020.
7. C2010628 - Drug Utilization Review 2020 [Service Award]. State Agency. Start Date: 2019. End Date: 2020.
8. C2015602 - 1815 Medication Therapy Management, Tele-MTM. Non-federal. Start Date: 2019. End Date: 2020.
9. C7069901 - MTM Drug Utilization Review. Non-federal. Start Date: 2019. End Date: 2020.
10. C7070101 - Study of Oklahoma Medicaid Assessing Outcomes Associated with Long-Acting Injectable Antipsychotics. Non-federal. Start Date: 2019. End Date: 2020.
Awards and Honors
- 1. Academy of Managed Care Pharmacy Nexus 2022, National Harbor, MD, Oct. 11-14, 2022. Top Conference Poster (Student, Matthew C. Dickson). Date: 2022.
2. Academy of Managed Care Pharmacy. Bronze Recognition. Date: 2015.
3. International Symposium of the Diabetic Foot. Top Conference Podium. Date: 2015.
Education
no results
Administrative Assignments
2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.